167 related articles for article (PubMed ID: 15464424)
1. Impact of genetic variation of PPARgamma in humans.
Meirhaeghe A; Amouyel P
Mol Genet Metab; 2004; 83(1-2):93-102. PubMed ID: 15464424
[TBL] [Abstract][Full Text] [Related]
2. Functional implications of genetic variation in human PPARgamma.
Jeninga EH; Gurnell M; Kalkhoven E
Trends Endocrinol Metab; 2009 Oct; 20(8):380-7. PubMed ID: 19748282
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in peroxisome proliferator-activated receptor gamma are associated with Type 2 diabetes mellitus and obesity in the Korean population.
Moon MK; Cho YM; Jung HS; Park YJ; Yoon KH; Sung YA; Park BL; Lee HK; Park KS; Shin HD
Diabet Med; 2005 Sep; 22(9):1161-6. PubMed ID: 16108843
[TBL] [Abstract][Full Text] [Related]
4. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
[TBL] [Abstract][Full Text] [Related]
5. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome.
Hahn S; Fingerhut A; Khomtsiv U; Khomtsiv L; Tan S; Quadbeck B; Herrmann BL; Knebel B; Müller-Wieland D; Mann K; Janssen OE
Clin Endocrinol (Oxf); 2005 May; 62(5):573-9. PubMed ID: 15853827
[TBL] [Abstract][Full Text] [Related]
6. Association of Pro12Ala polymorphism of PPARgamma gene with insulin resistance and related diseases.
Horiki M; Ikegami H; Fujisawa T; Kawabata Y; Ono M; Nishino M; Shimamoto K; Ogihara T
Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S63-7. PubMed ID: 15563983
[TBL] [Abstract][Full Text] [Related]
7. Lessons from human mutations in PPARgamma.
Hegele RA
Int J Obes (Lond); 2005 Mar; 29 Suppl 1():S31-5. PubMed ID: 15711581
[TBL] [Abstract][Full Text] [Related]
8. The role of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma in diabetes risk.
Tönjes A; Stumvoll M
Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):410-4. PubMed ID: 17563457
[TBL] [Abstract][Full Text] [Related]
9. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome.
Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Cakir N; Arslan M
Gynecol Endocrinol; 2006 Jun; 22(6):336-42. PubMed ID: 16785159
[TBL] [Abstract][Full Text] [Related]
10. Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus.
Tavares V; Hirata RD; Rodrigues AC; Monte O; Salles JE; Scalissi N; Speranza AC; Hirata MH
Diabetes Obes Metab; 2005 Sep; 7(5):605-11. PubMed ID: 16050954
[TBL] [Abstract][Full Text] [Related]
11. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
12. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome.
Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
Arch Med Res; 2006 Jan; 37(1):86-94. PubMed ID: 16314192
[TBL] [Abstract][Full Text] [Related]
13. Genetics of type 2 diabetes mellitus.
Malecki MT
Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S10-21. PubMed ID: 15955369
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of peroxisome proliferator-activated receptor gamma is not associated to Japanese ulcerative colitis.
Wang F; Tahara T; Arisawa T; Sakata M; Takahama K; Watanabe M; Hirata I; Nakano H
Hepatogastroenterology; 2008; 55(81):73-5. PubMed ID: 18507082
[TBL] [Abstract][Full Text] [Related]
15. Review: peroxisome proliferator-activated receptor-gamma and its role in the development and treatment of diabetes.
Leff T; Mathews ST; Camp HS
Exp Diabesity Res; 2004; 5(2):99-109. PubMed ID: 15203881
[TBL] [Abstract][Full Text] [Related]
16. Vascular placental abnormalities and newborn death in a pregnant diabetic woman with familial partial lipodystrophy type 3: a possible role for peroxisome proliferator-activated receptor γ.
Castell AL; Hiéronimus S; Lascols O; Fournier T; Fénichel P
Diabetes Metab; 2012 Oct; 38(4):367-9. PubMed ID: 22559930
[TBL] [Abstract][Full Text] [Related]
17. Rational discovery of a novel interface for a coactivator in the peroxisome proliferator-activated receptor gamma: theoretical implications of impairment in type 2 diabetes mellitus.
Shiraki T; Kodama TS; Jingami H; Kamiya N
Proteins; 2005 Feb; 58(2):418-25. PubMed ID: 15558556
[TBL] [Abstract][Full Text] [Related]
18. PPARγ mutations, lipodystrophy and diabetes.
Astapova O; Leff T
Horm Mol Biol Clin Investig; 2014 Nov; 20(2):63-70. PubMed ID: 25460295
[TBL] [Abstract][Full Text] [Related]
19. Phenomics, lipodystrophy, and the metabolic syndrome.
Hegele RA
Trends Cardiovasc Med; 2004 May; 14(4):133-7. PubMed ID: 15177263
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma and the regulation of adipocyte function: lessons from human genetic studies.
Gurnell M
Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):501-23. PubMed ID: 16311214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
